topSkip to main content

Menu, Secondary

Menu Trigger


Yale University

The combination of naltrexone and ketamine can help treat both symptoms of addiction and depression, a preliminary study by Yale University researchers suggests.
Yale researchers have identified a drinkable cocktail of designer molecules that interferes with a crucial first step of Alzheimer’s and even restores memories in mice.
Close to 9,000 children and teens in the United States died from opioid poisonings over the last two decades, representing a nearly three-fold increase in mortality rates, Yale researchers said.
A drug therapy used for patients with chronic heart failure also improves markers of poor prognosis in individuals who are hospitalized with acute heart failure, new Yale-led research shows.
A new Yale-led international study of individuals with alcohol dependence has identified gene variants that may help explain why some heavy drinkers suffer intense withdrawal symptoms when they try to stop drinking — some, less so.  
A genomic screening approach of more than 50,000 people shows that more than 80 percent of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don’t know it despite frequent interaction with the healthcare system.
New “Robotic Skins” technology developed by Yale researchers allows users to animate the inanimate and turn everyday objects into robots.
The gene editing technology CRISPR has prompted both breathless predictions of medical breakthroughs and warnings of the apocalypse. Dr. Greg Licholai, a biotech entrepreneur and a lecturer at Yale explains CRISPR’s potential and dangers.
Yale researchers have identified racial disparities in the treatment of patients who are prescribed opioids for chronic pain.
We only learn when there is uncertainty, says Yale University professor Daeyeol Lee